CBBT Projected Dividend Yield

Cerebain Biotech Corp ( OTCBB : CBBT )

Cerebain Biotech is a biomedical company. Through its wholly-owned subsidiary, Cerebain Operating, Inc., Co.'s business involves the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Omentum is a layer of tissue lying over internal organs (e.g. the intestines) like a blanket. Omentum has the ability to generate biological agents that nourish nerves and help them grow. The Omentum tissue can also increase the level of Acetylcholine whose reduction is considered as a main cause of brain cell death. Co. has the rights to certain intellectual property related to using Omentum for treating dementia conditions.

20 YEAR PERFORMANCE RESULTS